These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26461024)

  • 21. Is a "Puff to the Cuff" enough?: In regard to Alektiar et al. (Int J Radiat Oncol Biol Phys 2005;62: 111-117).
    Greven KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1275; author reply 1275. PubMed ID: 16253783
    [No Abstract]   [Full Text] [Related]  

  • 22. Is smaller better when it comes to the bladder?: in regard to Stewart et al. (Int J Radiat Oncol Biol Phys 2008;72:843-848).
    Stegman LD
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1287; author reply 1287-8. PubMed ID: 19251109
    [No Abstract]   [Full Text] [Related]  

  • 23. In regard to correspondence between Pötter et al. and Nag et al. (Int J Radiat Oncol Biol Phys 2005;62:293-295).
    Narayan K; vanDyk S; Bernshaw DL
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):644-5; author reply 645-7. PubMed ID: 16168857
    [No Abstract]   [Full Text] [Related]  

  • 24. In regard to D'Amico et al.: predictors of mortality after prostate-specific antigen failure (Int J Radiat Oncol Biol Phys 2006;65:656-660).
    Williams S
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1598; author reply 1598-9. PubMed ID: 17126225
    [No Abstract]   [Full Text] [Related]  

  • 25. Biologic comparisons of partial breast irradiation schedules: In regard to Rosenstein et al. (Int J Radiat Oncol Biol Phys 2004;60:1391-1404).
    Morgan DA
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):943; author reply 943-4. PubMed ID: 15936586
    [No Abstract]   [Full Text] [Related]  

  • 26. Erratum to: Pignol J-P, Vu TTT, Mitera G, et al. Prospective Evaluation of Severe Skin Toxicity and Pain During Postmastectomy Radiation Therapy. Int J Radiat Oncol Biol Phys 2015;91:157-164.
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):702. PubMed ID: 26068501
    [No Abstract]   [Full Text] [Related]  

  • 27. Erratum to: Melidis C, Bosch WR, Izewska J, et al. Global harmonization of quality assurance naming conventions in radiation therapy Clinical Trials. Int J Radiat Oncol Biol Phys 2014;90:1242-1249.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832708
    [No Abstract]   [Full Text] [Related]  

  • 28. In regards to Thames et al.: increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. (Int J Radiat Oncol Biol Phys 2006;65:975-981).
    Pickles T; Williams SG
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):318-9; author reply 319. PubMed ID: 17189080
    [No Abstract]   [Full Text] [Related]  

  • 29. Brachytherapy vs. IMRT for irradiation of the vaginal vault: in regard to Aydogan et al. (Int J Radiat Oncol Biol Phys 2006;65:266-273).
    Cameron A; Cornes P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):956; author reply 956-7. PubMed ID: 17011468
    [No Abstract]   [Full Text] [Related]  

  • 30. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy: in regard to Georg et al. (Int J Radiat Oncol Biol Phys 2011;79:356-362).
    Shi M; Wei L
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):315; author reply 315-6. PubMed ID: 21816293
    [No Abstract]   [Full Text] [Related]  

  • 31. Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172).
    Pötter R; Dimopoulos J; Kirisits C; Lang S; Haie-Meder C; Briot E; Dumas I; Van Limbergen E; De Brabandere M; Nulens A; Erickson B; Rownd J; Petrow P
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):293-5; author reply 295-6. PubMed ID: 15850940
    [No Abstract]   [Full Text] [Related]  

  • 32. Erratum to: Dawei Chen, Vivek Verma, Roshal R. Patel, et al. Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials. Int J Radiat Oncol Biol Phys 2020:108(1);196-203.
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):623. PubMed ID: 33989592
    [No Abstract]   [Full Text] [Related]  

  • 33. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: in regard to Kwan et al. (Int J Radiat Oncol Biol Phys 2004;60:1040-1046).
    Williams S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253-4; author reply 1254. PubMed ID: 15990030
    [No Abstract]   [Full Text] [Related]  

  • 34. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
    Vordermark D; Guckenberger M; Baier K; Markert K
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
    [No Abstract]   [Full Text] [Related]  

  • 35. Erratum to: Wilkins AC, Gusterson B, Szijgyarto Z, et al. Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2018;101:309-315.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967236
    [No Abstract]   [Full Text] [Related]  

  • 36. Erratum to: Jabbari S, Fitzmaurice T, Munoz F, et al. Cross-Border Collaboration in Oncology: A Model for United States-Mexico Border Health. Int J Radiat Oncol Biol Phys 2015;92:509-511.
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):472. PubMed ID: 26383691
    [No Abstract]   [Full Text] [Related]  

  • 37. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary on dose escalation and biochemical failure in prostate cancer: in regard to Eade et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207038
    [No Abstract]   [Full Text] [Related]  

  • 39. Erratum to: Nguyen PL. Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2016;94:975-977.
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1549. PubMed ID: 27479731
    [No Abstract]   [Full Text] [Related]  

  • 40. Erratum to: Rodrigues G, Oberije C, Senan S, et al. is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small cell lung cancer beneficial? A multi-institutional propensity score matched analysis. Int J Radiat Oncol Biol Phys 2015;91:133-139.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.